This result is in line with the data reported by Barschke and co-workers, who found no difference for UCHL1 levels in CSF of FTD patients carrying mutations in the C9orf72 gene with respect to non-carrier control subjects [44]. The gene discussed is C9orf72; the disease is frontotemporal dementia.